Literature DB >> 26845358

Long noncoding RNA-MEG3 is involved in diabetes mellitus-related microvascular dysfunction.

Gui-Zhen Qiu1, Wei Tian2, Hai-Tao Fu3, Chao-Peng Li4, Ban Liu5.   

Abstract

Microvascular dysfunction is an important characteristic of diabetic retinopathy. Long non-coding RNAs (lncRNAs) play important roles in diverse biological processes. In this study, we investigated the role of lncRNA-MEG3 in diabetes-related microvascular dysfunction. We show that MEG3 expression level is significantly down-regulated in the retinas of STZ-induced diabetic mice, and endothelial cells upon high glucose and oxidative stress. MEG3 knockdown aggravates retinal vessel dysfunction in vivo, as shown by serious capillary degeneration, and increased microvascular leakage and inflammation. MEG3 knockdown also regulates retinal endothelial cell proliferation, migration, and tube formation in vitro. The role of MEG3 in endothelial cell function is mainly mediated by the activation of PI3k/Akt signaling. MEG3 up-regulation may serve as a therapeutic strategy for treating diabetes-related microvascular complications.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetic retinopathy; Long noncoding RNA; Microvascular dysfunction; PI3k/Akt signaling

Mesh:

Substances:

Year:  2016        PMID: 26845358     DOI: 10.1016/j.bbrc.2016.01.164

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  68 in total

1.  Long noncoding RNA CA7-4 promotes autophagy and apoptosis via sponging MIR877-3P and MIR5680 in high glucose-induced vascular endothelial cells.

Authors:  Xuan Zhao; Le Su; Xiaoying He; Baoxiang Zhao; Junying Miao
Journal:  Autophagy       Date:  2019-04-07       Impact factor: 16.016

Review 2.  The crosstalk between long non-coding RNAs and PI3K in cancer.

Authors:  Leonidas Benetatos; Evangelos Voulgaris; Georgios Vartholomatos
Journal:  Med Oncol       Date:  2017-02-07       Impact factor: 3.064

3.  Long noncoding RNA MEG3 suppressed endothelial cell proliferation and migration through regulating miR-21.

Authors:  Ziheng Wu; Yangyan He; Donglin Li; Xin Fang; Tao Shang; Hongkun Zhang; Xiangtao Zheng
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

Review 4.  LncRNAs in vascular biology and disease.

Authors:  Viorel Simion; Stefan Haemmig; Mark W Feinberg
Journal:  Vascul Pharmacol       Date:  2018-02-06       Impact factor: 5.773

Review 5.  Long noncoding RNAs in cardiovascular disease, diagnosis, and therapy.

Authors:  Stefan Haemmig; Viorel Simion; Dafeng Yang; Yihuan Deng; Mark W Feinberg
Journal:  Curr Opin Cardiol       Date:  2017-11       Impact factor: 2.161

Review 6.  Dysregulated expression of long noncoding RNAs serves as diagnostic biomarkers of type 2 diabetes mellitus.

Authors:  Weiyue Zhang; Juan Zheng; Xiang Hu; Lulu Chen
Journal:  Endocrine       Date:  2019-07-25       Impact factor: 3.633

7.  Long noncoding RNA MALAT1 acts as a competing endogenous RNA to regulate Amadori-glycated albumin-induced MCP-1 expression in retinal microglia by a microRNA-124-dependent mechanism.

Authors:  Ning Dong; Bing Xu; Hong Shi
Journal:  Inflamm Res       Date:  2018-08-27       Impact factor: 4.575

8.  Molecular characterization of foveal versus peripheral human retina by single-cell RNA sequencing.

Authors:  A P Voigt; S S Whitmore; M J Flamme-Wiese; M J Riker; L A Wiley; B A Tucker; E M Stone; R F Mullins; T E Scheetz
Journal:  Exp Eye Res       Date:  2019-05-08       Impact factor: 3.467

9.  Long non-coding RNA LY86-AS1 and HCG27_201 expression in type 2 diabetes mellitus.

Authors:  Leyla Saeidi; Hamid Ghaedi; Mirsaber Sadatamini; Rouhollah Vahabpour; Ali Rahimipour; Mehrnoosh Shanaki; Zahra Mansoori; Faranak Kazerouni
Journal:  Mol Biol Rep       Date:  2018-10-16       Impact factor: 2.316

Review 10.  Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis.

Authors:  Binod Aryal; Yajaira Suárez
Journal:  Vascul Pharmacol       Date:  2018-03-15       Impact factor: 5.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.